Clinical Trials Browser

Phase 2 × Thyroid Diseases × 90 days × Clear all

NCT05660954 2026-04-02

CABOTHYROID

Phase 2 Active not recruiting

Neoplasms, Thyroid Diseases

NCT05059470 2026-03-23

IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC

Phase 2 Terminated

6 enrolled 8 charts

Thyroid Diseases